Agilent, 5064-8268, ZORBAX 300SB-C18 3.5µm, 0.5 x 150 mm

ZORBAX 300SB-C18 3.5µm, 0.5 x 150 mm. A reversed-phase C18 HPLC column with fully porous ZORBAX particles. StableBond technology ensures stability at low pH.

Specifications:
Brand: ZORBAX 300SB-C18
Hardware: SS
Inner Diameter (ID): 0.5 mm
LC Platform: Stainless Steel
Length: 150 mm
Maximum Temperature: 90 °C
Part Number Application Domain: Biopharma
Part Number Application: Monoclonal Antibodies (mABs)PeptidesProteins
Particle Size: 3.5 µm
Particle Type: Fully Porous
Phase: 300SB-C18
Pore Size: 300 Å
Pressure Rating: 400 bar
Separation Mode: Reversed Phase
Shipping Solvent: Acetonitrile/Water
Technique: LCLC & LC/MS
UNSPSC Code: 41115709
pH Range: 1-8

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The ZORBAX 300SB-C18 column features a 3.5 micron particle size with dimensions of 0.5 x 150 mm, delivering high-efficiency reverse phase separations. Specially designed for robust performance at low pH, it incorporates StableBond C18 chemistry on a 300 angstrom pore size silica, making it ideal for the analysis of large biomolecules such as peptides and small proteins. The narrow internal diameter allows for excellent sensitivity and minimal sample consumption, which is particularly beneficial for applications involving limited or valuable biological samples.

This column supports precise and reproducible separations in proteomics, peptide mapping, and pharmaceutical research workflows. Its compatibility with high-performance liquid chromatography (HPLC) and UHPLC systems from Agilent and other major manufacturers ensures seamless integration into existing laboratory setups. The advanced bonded phase technology provides outstanding peak shape and resolution, even under highly aqueous conditions, supporting reliable method development and validation.

In addition, this column aligns with other products in the ZORBAX StableBond family, facilitating method scalability and transfer. It is a preferred choice for core facilities, biotechnology labs, and pharmaceutical research teams demanding consistent results in biomolecule analysis.